Category

All

demonstration of FibroScan pulse when using probe

Battling liver disease

By All, Blog

Non-alcoholic fatty liver disease (NAFLD), affects approximately 100 million individuals in the United States. Its more serious form is called non-alcoholic steatohepatitis (NASH). NAFLD affects approximately 25% of the worldwide population and as many as 6% are affected by NASH, with NASH prevalence expected to increase by 63% by 2030.

Read More